| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:02 | Adia Nutrition Inc.: Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building | 108 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual... ► Artikel lesen | |
| 17.03. | Adia Nutrition Inc.: Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division | 393 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN... ► Artikel lesen | |
| 09.03. | Adia Nutrition Inc.: Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies | 440 | Newsfile | Orlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership... ► Artikel lesen | |
| ADIA NUTRITION Aktie jetzt für 0€ handeln | |||||
| 03.03. | Adia Nutrition Inc.: Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita | 326 | Newsfile | Winter Park, Florida--(Newsfile Corp. - March 3, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary... ► Artikel lesen | |
| 24.02. | Adia Nutrition Inc.: Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures | 131 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative wellness solutions through its subsidiary Adia Med... ► Artikel lesen | |
| 16.02. | Adia Nutrition Inc.: Adia Nutrition Announces Subsidiary Adia Med's Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita | 301 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 16, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary... ► Artikel lesen | |
| 09.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Plans to Initiate Four to Five New Clinical Studies in 2026, Including Expansions in Autism and New Rheumatoid Arthritis Research | 308 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 9, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its subsidiary Adia Med, today announced an ambitious expansion... ► Artikel lesen | |
| 04.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Announces Effectiveness of Form 10 Registration Statement - Now a Fully Reporting SEC Company and Advancing Toward Next Phase of Growth and NASDAQ Uplisting | 307 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 4, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its... ► Artikel lesen | |
| 02.02. | Adia Nutrition Inc.: Adia Nutrition Inc. Announces Dr. Brian Browning as Lead Physician for All Orthopedic Treatments and Specialties at Adia Med | 267 | Newsfile | Winter Park, Florida--(Newsfile Corp. - February 2, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its... ► Artikel lesen | |
| 28.01. | Adia Nutrition Inc.: Adia Nutrition Announces Documentary Featuring WWE/TNA Superstar Elias/Elijah Jeff Sciullo's Recovery with Adia Med's AdiaVita Stem Cell Treatment | 529 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 28, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in regenerative therapies, is proud to announce... ► Artikel lesen | |
| 26.01. | Adia Nutrition Inc.: Adia Nutrition Announces Every Child in Autism Stem Cell Study Receives Umbilical Cord Blood-Derived Stem Cell Treatments Three Times - Open Nationwide and Worldwide with Participation Cost | 327 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its subsidiary Adia Med of Winter Park, LLC, today highlighted key details of its ongoing IRB-approved... ► Artikel lesen | |
| 20.01. | Adia Nutrition Inc.: Adia Nutrition Inc. Receives Notification from SEC: Form 10 to Become Effective on February 3, 2026 | 323 | Newsfile |
Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified... ► Artikel lesen | |
| 15.01. | Adia Nutrition Inc.: Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study | 334 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that... ► Artikel lesen | |
| 13.01. | Adia Nutrition Inc.: Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study | 343 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment... ► Artikel lesen | |
| 08.01. | ADIA Nutrition appoints Dawn Bell as chief revenue officer | 1 | Investing.com | ||
| 08.01. | Adia Nutrition Inc.: ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network | 256 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as... ► Artikel lesen | |
| 05.01. | Adia Nutrition Inc.: Adia Nutrition Inc. Announces Landmark Autism Spectrum Disorder Clinical Study Now Live on ClinicalTrials.gov | 398 | Newsfile | Winter Park, Florida--(Newsfile Corp. - January 5, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today announced that its... ► Artikel lesen | |
| 29.12.25 | Adia Nutrition Inc.: Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting | 331 | Newsfile | Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced... ► Artikel lesen | |
| 17.12.25 | Adia Nutrition Inc.: Adia Labs Launches Turnkey Clinic Model for Chiropractic Practices with BoldMD | 307 | Newsfile | Winter Park, Florida--(Newsfile Corp. - December 17, 2025) - Adia Labs, a division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a strategic marketing partnership with BoldMD, a leading... ► Artikel lesen | |
| 15.12.25 | Adia Nutrition Inc.: Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med's Autism Clinical Study | 348 | Newsfile | Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med subsidiary, today announced that the independent... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,950 | +1,28 % | EQS-DD: Fresenius Medical Care AG: Helen Pring Giza, Kauf von Aktien unter dem Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Zuteilung 2023) | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.03.2026 / 09:28... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 36,790 | +0,35 % | EQS-DD: Siemens Healthineers AG: Dorothea Simon, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 16:23... ► Artikel lesen | |
| FRESENIUS | 44,080 | +0,18 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
20.03.2026 / 09:22... ► Artikel lesen | |
| GERRESHEIMER | 20,160 | +6,95 % | Gerresheimer: Übernahmegerüchte! | Der hoch verschuldete Spezialverpackungshersteller Gerresheimer ist nach einer Reihe von Gewinnwarnungen und bekanntgewordenen Bilanzierungsproblemen massiv unter Druck geraten. Der Börsenwert liegt... ► Artikel lesen | |
| OTTOBOCK | 54,35 | +8,96 % | Ottobock: Rekordtief für die Aktie - Dividende höher als erwartet | Der deutsche Prothesenhersteller ist im vergangenen Jahr zum Ausgabepreis von 66 Euro je Aktie an die Börse gegangen. Stand heute ist die Performance des SDAX-Mitglieds enttäuschend: Am Donnerstag rutscht... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,120 | -2,96 % | EQS-DD: Eckert & Ziegler SE: Dr. Harald Hasselmann, Zuteilung von 62.541 Aktien als Vergütungsbestandteil im Rahmen der Vorstandsvergütung (eigene Aktien des Emittenten). Es handelt sich um ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
24.03.2026 / 10:04... ► Artikel lesen | |
| ENVUE MEDICAL | 2,380 | +66,43 % | ENvue Medical Shares Jump 45% After Hospital Platform Expansion | ||
| CARL ZEISS MEDITEC | 24,080 | +2,82 % | Ihre wichtigsten Termine: Spannende Updates von: Fedex, Continental, Docmorris, Carl Zeiss Meditec und 1&1 | © Foto: Kevin Wolf - FR33460 APGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| UNITEDHEALTH | 235,00 | -2,27 % | UnitedHealth-Aktie: Droht der Totalverlust für Anleger? | ||
| DRAEGERWERK | 92,40 | +4,52 % | Ihre wichtigsten Termine: Frische Zahlen von: Kingfisher, Drägerwerk & Bellway sowie neue Konjunkturdaten | © Foto: Axel Heimken - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:30... ► Artikel lesen | |
| ESSILORLUXOTTICA | 192,60 | -0,75 % | RBC stuft EssilorLuxottica auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für EssilorLuxottica auf "Outperform" mit einem Kursziel von 320 Euro belassen. Die von ihm beobachteten europäischen Luxusgüterwerte... ► Artikel lesen | |
| GENEDX | 68,84 | -4,57 % | GeneDx (WGS), Zevra Therapeutics (ZVRA) Partner to Launch Sponsored Genetic Testing Program for NPC | ||
| BRIGHTSPRING HEALTH SERVICES | 42,920 | +1,90 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| BILLIONTOONE | 79,86 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,170 | -1,94 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen |